Cargando…

Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation

Few studies have compared outcomes in patients undergoing liver transplantation (LT) for hepatitis B virus (HBV) and alcoholic liver disease (ALD) in Asian countries in which living donor LT (LDLT) is dominant, where HBV is endemic and where there are no strict regulations on pre-transplant abstinen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Suk Kyun, Yi, Nam-Joon, Kim, Hyo-Sin, Ahn, Sung Woo, Yoon, Kyung Chul, Kim, Hyeyoung, Lee, Kwang-Woong, Suh, Kyung-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426245/ https://www.ncbi.nlm.nih.gov/pubmed/28480648 http://dx.doi.org/10.3346/jkms.2017.32.6.919

Ejemplares similares

Fatigue and related factors after liver transplantation
por: Hong, Kwangpyo, et al.
Publicado: (2015)

Impact of Model for End-Stage Liver Disease allocation system on outcomes of deceased donor liver transplantation: A single-center experience
por: Park, Han Sang, et al.
Publicado: (2021)

Outcomes of Split Liver Transplantation vs Living Donor Liver Transplantation in Pediatric Patients: A 5-Year Follow-Up Study in Korea
por: Yoon, Kyung Chul, et al.
Publicado: (2022)

Comparative Peripheral Blood T Cells Analysis Between Adult Deceased Donor Liver Transplantation (DDLT) and Living Donor Liver Transplantation (LDLT)
por: Kim, Jong Man, et al.
Publicado: (2017)

Wearable recording video technology for surgical training in living donor liver transplantation
por: Lee, Shin Ae, et al.
Publicado: (2020)

The Model for End-Stage Liver Disease Score-Based System Predicts Short Term Mortality Better Than the Current Child-Turcotte-Pugh Score-Based Allocation System during Waiting for Deceased Liver Transplantation
por: Hong, Geun, et al.
Publicado: (2013)

Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
por: Park, Min-Su, et al.
Publicado: (2014)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014)

Outcomes of deceased donor liver transplantation from elderly donors
por: Kim, Minjae, et al.
Publicado: (2021)

Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume
por: Hong, Geun, et al.
Publicado: (2014)

Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
por: Suh, Suk-Won, et al.
Publicado: (2016)

Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Yoo, Tae, et al.
Publicado: (2016)

Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma
por: Lee, Hwi Yeol, et al.
Publicado: (2021)

Pretransplantation fetal-maternal microchimerism in pediatric liver transplantation from mother
por: Yi, Nam-Joon, et al.
Publicado: (2017)

Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation
por: Kim, Min Seob, et al.
Publicado: (2022)

Whole liver deceased donor liver transplantation for pediatric recipients: single-center experience for 20 years
por: Namgoong, Jung-Man, et al.
Publicado: (2020)

Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2015)

Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2023)

No diffuse intrahepatic biliary stricture after ABO-incompatible adult living donor liver transplantation using tailored rituximab-based desensitization protocol
por: Natsuda, Koji, et al.
Publicado: (2021)

Korea-nationwide incidence of pediatric deceased donors and single-institutional status of liver transplantation using pediatric donor liver grafts
por: Namgung, Jung-Man, et al.
Publicado: (2020)

Pediatric deceased donor liver transplantation with in situ size reduction for recipient-graft size matching
por: Namgoong, Jung-Man, et al.
Publicado: (2021)

UPPER MIDLINE INCISION IN RECIPIENTS OF DECEASED-DONORS LIVER TRANSPLANTATION
por: da FONSECA-NETO, Olival Cirilo Lucena, et al.
Publicado: (2018)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
por: Lee, Ju-Yeun, et al.
Publicado: (2014)

Biliary Complications after Living Donor Liver Transplantation Differ from Those after Deceased Donor Liver Transplantation
por: Jang, Sung Ill, et al.
Publicado: (2022)

Living Donor Liver Transplantation for an Infant with Osteogenesis Imperfecta and Intrahepatic Cholestasis: Report of a Case
por: Choi, YoungRok, et al.
Publicado: (2014)

Outcomes of kidney transplantation from elderly deceased donors of a Korean registry
por: Jun, Heungman, et al.
Publicado: (2020)

Acute appendicitis after liver transplantation: A single center experience and review of the literature
por: Jamtani, Indah, et al.
Publicado: (2020)

Liver Transplantation for Metabolic Liver Disease: Experience at a Living Donor Dominant Liver Transplantation Center
por: Kim, Jun Suk, et al.
Publicado: (2015)

Transplantation of Deceased Donor Livers With Elevated Levels of Serum Transaminases at Shiraz Transplant Center
por: Fakhar, Nasir, et al.
Publicado: (2016)

Effects of infection on post-transplant outcomes: living versus deceased donor liver transplants
por: Siddique, Osama, et al.
Publicado: (2018)

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020)

Long-Term Survival Outcomes beyond the First Year after Liver Transplantation in Pediatric Acute Liver Failure Compared with Biliary Atresia: A Large-Volume Living Donor Liver Transplantation Single-Center Study
por: Lee, Sola, et al.
Publicado: (2022)

Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series
por: Simsek, Cem, et al.
Publicado: (2020)

Outcomes of Patients with Benign Liver Diseases Undergoing Living Donor versus Deceased Donor Liver Transplantation
por: Li, Chuan, et al.
Publicado: (2011)

Outcomes in Adult Liver Transplant Recipients Using Pediatric Deceased Donor Liver Grafts
por: Vargas, Paola A., et al.
Publicado: (2022)

Duct of Luschka Bile Leak Following Deceased Donor Liver Transplant
por: Ord, Jeffrey R., et al.
Publicado: (2021)

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in liver transplantation
por: Cho, Ara, et al.
Publicado: (2021)

Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial
por: Lee, Kwang-Woong, et al.
Publicado: (2020)

Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation
por: Lee, Jisun, et al.
Publicado: (2021)

Long Term Outcomes of Pediatric Liver Transplantation According to Age
por: Byun, Jeik, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_snhjlkmc9mdsu8bf0devg992fn